(19)
(11) EP 1 091 949 A2

(12)

(88) Date of publication A3:
10.02.2000

(43) Date of publication:
18.04.2001 Bulletin 2001/16

(21) Application number: 99930727.5

(22) Date of filing: 25.06.1999
(51) International Patent Classification (IPC)7C07D 311/04, C07D 307/79, C07D 319/18, C07D 321/10, C07D 313/08, C07D 405/04
(86) International application number:
PCT/US9914/426
(87) International publication number:
WO 0000/489 (06.01.2000 Gazette 2000/01)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.06.1998 US 109242

(71) Applicant: NEUROGEN CORPORATION
Branford, CT 06405 (US)

(72) Inventors:
  • TRAN, Jennifer, N.
    Guilford, CT 06437 (US)
  • THURKAUF, Andrew
    Danbury, CT 06811 (US)

(74) Representative: W.P. THOMPSON & CO. 
Celcon House289-293 High Holborn
London WC1V 7HU
London WC1V 7HU (GB)

   


(54) 6-(4-ARYLALKYLPIPERAZIN-1-YL)BENZODIOXANE AND 6-(4-ARYLALKYLPIPERAZIN-1-YL)CHROMANE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS